CARMAT announces the first implant of its Aeson total artificial heart in The Netherlands

CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure,announces the first implant of theAeson artificial heart in The Netherlands.

The implant procedure was performed by theHeart Team led byDr.Faiz Z. Ramjankhanand Dr.Niels P. van der Kaaij, Cardiothoracicsurgeons,and Dr. Linda W. van Laake, heart failure Cardiologist, at the University Medical Center (UMC) Utrecht, The Netherlands. The implant took place in the frame of the European PIVOTAL Study. It was the first time ever that atotalartificial heart was implanted in The Netherlands.UMC Utrechtisone of the three heart transplantation centers in the countryandthe most experienced Mechanical Circulatory Support (MCS) center, having implanted the first MCS in the countryin 1993.